Radiofrequency Ablation of Lung Tumors
Lung Cancer, Metastasis
About this trial
This is an interventional treatment trial for Lung Cancer focused on measuring Lung metastasis, Lung cancer, Radiofrequency ablation
Eligibility Criteria
Inclusion Criteria: Unilateral or bilateral unresectable primary or metastatic lung tumors <= 40 mm and a number of tumor <=5 Tumors located more than 1 cm from the hilum, and not involving soft tissues or mediastinum. Malignancy histologically proven for pulmonary nodules in patients with no history of cancer outside the lung. Lung tumors in patients with a known distant cancer history, has to be either histologically proven or a demonstrated change in size of at least 25% in their largest diameter is required on CT during the previous year Pretreatment imaging work-up within 4 weeks of scheduled RF ablation (at least a chest CT and an abdomino-pelvic CT) If a tumor is found outside the lung, it has to be amenable to complete eradication with RF or RF plus surgery Lung spirometry within 4 weeks of treatment with a FEV1 >= 1 liter Written informed consent. Exclusion Criteria: Uncorrectable coagulopathy with a prothrombin time greater than 1.5 and a platelet count below 106/mm3
Sites / Locations
- Institut Bergonié
- Institut Gustave Roussy